Search Results

There are 7523 results for: content related to: Clinical trial: once-daily mesalamine granules for maintenance of remission of ulcerative colitis – a 6-month placebo-controlled trial

  1. You have free access to this content
    Aminosalicylates for induction of remission or response in Crohn's disease

    Intervention Review

    The Cochrane Library

    Wee-Chian Lim, Yongjun Wang, John K MacDonald and Stephen Hanauer

    Published Online : 3 JUL 2016, DOI: 10.1002/14651858.CD008870.pub2

  2. Therapeutic Approaches to the Treatment of Ulcerative Colitis

    Inflammatory Bowel Disease: Translating basic science into clinical practice

    Stephan R. Targan, Fergus Shanahan, Loren C. Karp, Pages: 415–443, 2010

    Published Online : 18 MAY 2010, DOI: 10.1002/9781444318418.ch28

  3. You have free access to this content
    Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis

    Intervention Review

    The Cochrane Library

    Yongjun Wang, Claire E Parker, Tania Bhanji, Brian G Feagan and John K MacDonald

    Published Online : 21 APR 2016, DOI: 10.1002/14651858.CD000543.pub4

  4. Strategies in maintenance for patients receiving long-term therapy (SIMPLE): A study of MMX mesalamine for the long-term maintenance of quiescent ulcerative colitis

    Inflammatory Bowel Diseases

    Volume 18, Issue 6, June 2012, Pages: 1026–1033, Sunanda Kane, Seymour Katz, M. Mazen Jamal, Michael Safdi, Ben Dolin, Dory Solomon, Mary Palmen and Karen Barrett

    Version of Record online : 11 AUG 2011, DOI: 10.1002/ibd.21841

  5. Crohn's is not a 6-week disease. Lifelong management of mild to moderate Crohn's disease

    Inflammatory Bowel Diseases

    Volume 10, Issue 8, July 2004, Pages: S2–S10, Gary R. Lichtenstein, Stephen B. Hanauer, Sunanda V. Kane and Daniel H. Present

    Version of Record online : 14 DEC 2006, DOI: 10.1097/00054725-200407002-00002

  6. Chemistry, Pharmacology, Pharmacokinetics, and Clinical Applications of Mesalamine for the Treatment of Inflammatory Bowel Disease

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 14, Issue 4, July-August 1994, Pages: 385–398, Ralph E. Small and Charles C. Schraa

    Version of Record online : 18 JAN 2012, DOI: 10.1002/j.1875-9114.1994.tb02829.x

  7. You have free access to this content
    Once-daily versus multiple-daily mesalamine for patients with ulcerative colitis: A meta-analysis

    Journal of Digestive Diseases

    Volume 13, Issue 4, April 2012, Pages: 200–207, Jin Lu TONG, Mei Lan HUANG, Xi Tao XU, Yu Qi QIAO and Zhi Hua RAN

    Version of Record online : 21 MAR 2012, DOI: 10.1111/j.1751-2980.2012.00576.x

  8. You have free access to this content
    Once daily oral mesalamine compared to conventional dosing for induction and maintenance of remission in ulcerative colitis: A systematic review and meta-analysis

    Inflammatory Bowel Diseases

    Volume 18, Issue 9, September 2012, Pages: 1785–1794, Brian G. Feagan and John K. MacDonald

    Version of Record online : 29 MAY 2012, DOI: 10.1002/ibd.23024

  9. Once daily vs multiple daily mesalamine therapy for mild to moderate ulcerative colitis: a meta-analysis

    Colorectal Disease

    Volume 18, Issue 7, July 2016, Pages: O214–O223, W. Li, Z.-M. Zhang and X.-L. Jiang

    Version of Record online : 4 JUL 2016, DOI: 10.1111/codi.13393

  10. Possible Mesalamine-Induced Pericarditis: Case Report and Literature Review

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 22, Issue 3, March 2002, Pages: 391–394, Robert A. Waite and Jennifer M. Malinowski

    Version of Record online : 17 JAN 2012, DOI: 10.1592/phco.22.5.391.33188

  11. State of the art: IBD therapy and clinical trials in IBD

    Inflammatory Bowel Diseases

    Volume 11, Issue S1, November 2005, Pages: S3–S12, Kim L Isaacs, James D Lewis, William J Sandborn, Bruce E Sands and Stephan R Targan

    Version of Record online : 14 DEC 2006, DOI: 10.1097/01.MIB.0000184852.84558.b2

  12. Impact of MMX® mesalamine on improvement and maintenance of health-related quality of life in patients with ulcerative colitis

    Inflammatory Bowel Diseases

    Paul Hodgkins, Linnette Yen, Aaron Yarlas, Robyn Karlstadt, Dory Solomon and Sunanda Kane

    Version of Record online : 30 MAY 2012, DOI: 10.1002/ibd.23022

  13. Maintaining remissions across the lifespan. A roundtable discussion with Crohn's disease experts

    Inflammatory Bowel Diseases

    Volume 10, Issue 8, July 2004, Pages: S11–S21, Gary R. Lichtenstein, Carmen Cuffari, Sunanda V. Kane, Stephen Hanauer and Daniel H. Present

    Version of Record online : 14 DEC 2006, DOI: 10.1097/00054725-200407002-00003

  14. Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis

    Intervention Review

    The Cochrane Library

    Vipul Jairath, GY Zou, Claire E Parker, John K MacDonald, Turki AlAmeel, Mohammad Al Beshir, Majid A Almadi, Talal Al-Taweel, Nathan SS Atkinson, Sujata Biswas, Thomas Chapman, Parambir S Dulai, Mark A Glaire, Daniël R Hoekman, Andreas Koutsoumpas, Elizabeth Minas, Mahmoud H Mosli, Mark Samaan, Reena Khanna, Simon Travis, Geert D'Haens, William J Sandborn and Brian G Feagan

    Published Online : 8 SEP 2017, DOI: 10.1002/14651858.CD011572.pub2

  15. Interventions for treating collagenous colitis

    Intervention Review

    The Cochrane Library

    Tahir S Kafil, Tran M Nguyen, Petrease H Patton, John K MacDonald, Nilesh Chande and John WD McDonald

    Published Online : 11 NOV 2017, DOI: 10.1002/14651858.CD003575.pub6

  16. Clinical trial: A novel high-dose 1 g mesalamine suppository (salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis

    Inflammatory Bowel Diseases

    Volume 16, Issue 11, November 2010, Pages: 1947–1956, Tilo Andus, Andreas Kocjan, Moritz Müser, Andrey Baranovsky, Tatyana L. Mikhailova, Tatyana D. Zvyagintseva, Andrey E. Dorofeyev, Yurii S. Lozynskyy, Ingolf Cascorbi, Manfred Stolte, Michael Vieth, Karin Dilger, Ralf Mohrbacher and Roland Greinwald

    Version of Record online : 22 MAR 2010, DOI: 10.1002/ibd.21258

  17. Therapeutic strategies for the management of ulcerative colitis

    Inflammatory Bowel Diseases

    Volume 15, Issue 6, June 2009, Pages: 935–950, Siew C. Ng and Michael A. Kamm

    Version of Record online : 4 NOV 2008, DOI: 10.1002/ibd.20797

  18. Effect of extended MMX mesalamine therapy for acute, mild-to-moderate Ulcerative Colitis

    Inflammatory Bowel Diseases

    Volume 15, Issue 1, January 2009, Pages: 1–8, Michael A. Kamm, Gary R. Lichtenstein, William J. Sandborn, Stefan Schreiber, Kirstin Lees, Karen Barrett and Raymond Joseph

    Version of Record online : 31 JUL 2008, DOI: 10.1002/ibd.20580

  19. You have free access to this content
    Mild to moderate Crohn's disease – defining the basis for a new treatment algorithm

    Alimentary Pharmacology & Therapeutics

    Volume 18, Issue 3, August 2003, Pages: 263–277, W. J. Sandborn and B. G. Feagan

    Version of Record online : 25 JUL 2003, DOI: 10.1046/j.1365-2036.2003.01661.x

  20. Crohn's Disease

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 15 SEP 2006, DOI: 10.1002/9780470041000.cedt019